Federal Court Overturns Gilead Sciences and Merck Patent Dispute Post author:Sam Post published:February 19, 2018 Post category:BioPharma Federal court judge orders Merck to repay $2.5 Billion to Gilead in overturned patent decision. Source: BioSpace You Might Also Like NuVasive Reports Fourth Quarter And Full Year 2016 Financial Results February 9, 2017 Genentech Dumps Another $650M in New Haven Biotech Arvinas November 14, 2017 San Diego-based Biotech Expands for Future Growth and Top Talent August 6, 2017